Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
29%
OVERLAP
BY WEIGHT
4
# OF OVERLAPPING
HOLDINGS
OZEM
21
HOLDINGS
19%
ALSO IN MEDX
MEDX
27
HOLDINGS
15%
ALSO IN OZEM
SECTOR DRIFT (OZEM minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in OZEM |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.8% | 21.2% | 15.8% |
|
AMGEN INC | 4.9% | 4.9% | 4.9% |
 |
ASTRAZENECA PLC | 4.5% | 4.8% | 4.5% |
|
PFIZER INC | 8.4% | 3.5% | 3.5% |
OZEM Overweight Relative to MEDX
 |
NOVO-NORDISK A/S-SPONS ADR | 11.9% |
|
KAILERA THERAPEUTICS INC | 5.9% |
 |
ASCLETIS PHARMA, INC. | 5.4% |
 |
CHINA PHARMACEUTICAL GROUP | 5.2% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 5.1% |
|
PFIZER INC | 4.8% |
|
VIKING THERAPEUTICS, INC. | 4.6% |
 |
HANMI PHARM CO LTD | 3.6% |
|
ZEALAND PHARMA A/S | 3.5% |
|
JIANGSU HENGRUI PHARMACEUT-H | 3.0% |
OZEM Underweight Relative to MEDX
|
ABBVIE INC | -10.1% |
 |
NOVARTIS AG-ADR | -6.9% |
|
JOHNSON & JOHNSON | -5.8% |
|
ELI LILLY & CO | -5.4% |
 |
ALKERMES PLC | -4.6% |
|
MERCK & CO. INC. | -4.5% |
|
BRISTOL-MYERS SQUIBB CO | -4.2% |
|
BIOGEN IDEC INC | -3.5% |
|
REGENERON PHARMACEUTICALS | -3.0% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.5% |